Tue., Oct. 12, 2021: Join our Webcast – TissueInsight®: Realizing the Clinical Diagnostic Potential of Digital Pathology.

Our sophisticated tissue image analysis gives you a distinct advantage in drug development and clinical diagnostics

Powered by award-winning, proprietary technology and a multidisciplinary team of experts, Flagship Biosciences brings simplicity to a complicated pathology world.

From developing and validating an assay to employing the most comprehensive image analysis data, we provide a full, end-to-end solution for discovering and contextualizing the most relevant endpoints in a CAP/CLIA or RUO setting.

Our unique, proprietary image analysis technology provides thousands of measurements on every cell across an entire slide for data-centric pathology insights on every sample. Flagship’s technology, team, and proven process have provided superior data for hundreds of clinical trials.

The Flagship approach:

  • Saves time and money in predicting patient response and demonstrating mechanisms of action
  • Dramatically improves accuracy
  • Accelerates the development process through more robust data
  • Enriches the clinical diagnostics decision-making process

Quite simply, we’re changing the drug development paradigm.

Our Services

Pharma

Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.

Clinical Diagnostics

Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.

Benefits of Collaborating with Flagship

More accurate and informative tissue data and analytics

Collaboration with our world-renowned scientific team

Increased speed to market for your drug development programs

Enriched clinical diagnostics process for better outcomes